Universal Biosensors surges 60% on FDA approval for Class II device
Universal Biosensors shares surged 60% following the attainment of US Food and Drug Administration and Clinical Laboratory Improvement Amendments Waiver approvals.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
FIE | new code | 10/05/16 | 9 | 4.9K | |||
|
|||||||
FIE | Ann: Becoming a substantial holder-FIE.AX | 22/04/16 | 0 | 854 | |||
|
|||||||
FIE | Ann: Appendix 3B-FIE.AX | 22/04/16 | 0 | 706 | |||
|
|||||||
FIE | Ann: Final Director's Interest Notice-FIE.AX | 22/04/16 | 0 | 821 | |||
|
|||||||
FIE | Ann: Final Director's Interest Notice-FIE.AX | 22/04/16 | 0 | 729 | |||
|
|||||||
FIE | Ann: Final Director's Interest Notice-FIE.AX | 22/04/16 | 0 | 778 | |||
|
|||||||
FIE | Ann: Initial Director's Interest Notice-FIE.AX | 22/04/16 | 0 | 698 | |||
|
|||||||
FIE | Ann: Initial Director's Interest Notice-FIE.AX | 22/04/16 | 0 | 603 | |||
|
See All Discussions